This review conjugates the current knowledge of purinergic signaling in cancer biology with techniques involving nanomaterials to increase anticancer immune responses.
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
Ferrari, DavidePrimo
Writing – Original Draft Preparation
;Gessi, StefaniaSecondo
Writing – Original Draft Preparation
;Merighi, Stefania
Writing – Original Draft Preparation
;Nigro, ManuelaWriting – Review & Editing
;Travagli, AlessiaPenultimo
;Burns, Jorge S.Ultimo
Writing – Original Draft Preparation
2022
Abstract
This review conjugates the current knowledge of purinergic signaling in cancer biology with techniques involving nanomaterials to increase anticancer immune responses.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
fcell-10-893709 (1).pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Full text (versione editoriale)
Licenza:
Creative commons
Dimensione
1.22 MB
Formato
Adobe PDF
|
1.22 MB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
